A review of the anti-viral effects of ivermectin
B Adegboro, O A Lawani, S E Oriaifo, S A Abayomi
African Journal of Clinical and Experimental Microbiology, doi:10.4314/ajcem.v22i3.2
Ivermectin is an avermectin which is a group of pentacyclic sixteen-membered lactone (macrocyclic lactone disaccharide) derived from the soil bacterium Streptomyces avermitilis. It is a semi-synthetic broad-spectrum antihelminthic, anti-viral and anti-cancer agent. It has a wide safety margin with low adverse effects when it is used orally. It has, however, so far only been approved by the Food and Drug Administration (FDA) as a broad spectrum anti-parasitic agent. Because ivermectin also has broad activities as an anti-viral agent, we herein review its pharmacokinetic and pharmacodynamic activities, as well as the in vitro and in vivo studies conducted on the drug. It is hoped that this work will pave way for ivermectin being seriously considered as an addition to the drugs available for the management of patients with COVID-19.
References
Azeem, Ashraff, Rasheed, Anjum, Hameed, Evaluation of cytotoxic and antiviral activity of ivermectin against Newcastle disease virus, Pak J Pharm Sci
Banerjee, Nandy, Dalai, Ahmed, The battle against COVID-19 pandemic: What we need to know before we "test fire" ivermectin, Drug Res (Stuttg.)
Barrows, Campos, Powell, A screen of FDA-drugs, for inhibitors of Zika virus infection, Cell Host Microbe
Basanez, Pion, Boakes, Effect of single-dose ivermectin on Onchocerca volvulus: A systematic review and meta-analysis, Lancet Infect Dis
Bennet, Zhao, Bosard, Imperiale, Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry, Virology
Berthomme, Monahan, Parris, Jacquemont, Epstein, Cloning, sequencing, and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction, J Virol
Borst, Schinkel, What have learnt thus far from mice with disrupted p-glycoprotein genes?, Eur J Cancer
Bray, Rayner, Noel, Jans, None
Caly, Druce, Catton, Jans, Wagstaff, The FDA approved drug Ivermectin inhibit replication of SARS-CoV-2 in vitro, Antiviral Res
Caly, Druce, Catton, Jans, Wagstaff, The FDA-approved drug ivermectin inhibits the replication of SARS-COV-2 in vitro, Antivir Res
Caly, Druce, Catton, Jans, Wagstaff, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antivir Res
Caly, Wagstaff, Jans, Nuclear trafficking of proteins from RNA viruses: Potential target for antivirals?, Antivir Res
Canga, Prieto, Liebana, Martinez, Vega, The pharmacokinetics and interactions of ivermectin-a minireview, AAPS J
Carmona-Guttierrez, Bauer, Zimmermann, Digesting the crisis: Autophagy and coronavirus, Microb Cell,
doi:.10.15698/.05.715Didier, Loor, The abamectin derivative ivermectin is a potent p-glycoprotein inhibitor, Anti-Cancer Drugs
Dou, Chen, Wang, Ivermectin induces cytostatic autophagy by blocking the PAK/AKT axis in breast cancer, Cancer Res
González Canga, Sahagún Prieto, Diez Liébana, The pharmacokinetics and interaction of ivermectin in humans: a mini-review, AAPS J,
doi:10.1208/s12248-007-9000-9Gotz, Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import, Sci Rep
Gotz, Magar, Dornfeld, Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import, Sci Rep
Juarez, Schcolnik-Cabrera, Duenas-Gonzalez, The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug, Am J Cancer Res
Lundberg, Pinkham, Baer, Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication, Antivir Res
Lv, Liu, Wang, Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo, Antivir Res
Lv, Liu, Wang, Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo, Antivir Res
Mudatsir, Yufika, Nainu, Antiviral activity of ivermectin against SARS-CoV-2: An old-fashioned dog with a new trick -a literature review, Scientia Pharmaceutica,
doi:10.3390/scipharm88030036Nicolas, Maia, Bassat, Safety of oral ivermectin during pregnancy: A systematic review and meta-analysis, Lancet Glob Health
Rajter, Sherman, Fatteh, Ivermectin in COVID Nineteen) study: Use of ivermectin is associated with lower mortality in hospitalized patients with COVID-19, MedRxiv,
doi:10.1101/2020.06.06.2012446Raza, Shahin, Zhai, Ivermectin inhibits bovine herpesvirus-1 DNA polymerase nuclear import and interferes with viral replication, Microorganisms,
doi:10.3390/microorganisms8030409Rizzo, Ivermectin, antiviral properties and COVID-19: A possible new mechanism of action, Nauyn-Schmeid Acta Pharmacol
Schmith, Zhou, Lohmer, The approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19, Clin Pharmacol Ther
Slonska, Cymerys, Skwarska, Golke, Banbura, Influence of importin alpha/beta and exportin 1 on Equine herpesvirus type 1 (EHV-1) replication in primary murine neurons, Pol J Vet Sci
Tay, Fraser, Chan, Nuclear localization of dengue virus (DENV) 1-4 non -structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin, Antivir Res
Velthuis, Van Den Worm, Sims, Zn 2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, PLoS Pathol
Wagstaff, Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses, Antivir. Res
Wagstaff, Rawlinson, Hearps, Jans, An Alpha Screen (R)-based assay for high throughput screening for specific inhibitor of nuclear import, J Biomol Screen
Wagstaff, Sivakumaran, Heaton, Harrich, Jans, Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import to inhibit replication of HIV-1 and dengue virus, Biochem J
Wagstaff, Sivakumaran, Heaton, Harrich, Jans, Ivermectin is a specific inhibitor of importinα/β -mediated nuclear import able to inhibit replication of HIV-1 and dengue virus, Biochem J
Wang, Du, Huang, The pseudorabies virus DNA polymerase accessory subunit UL42 directs nuclear transport of the holoenzyme, Front Microbiol
Yang, Atkinson, Wang, The broad spectrum antiviral ivermectin targets the host nuclear transport import α/β1 heterodimer, Antivir Res
Yang, Atkinson, Wang, The broad-spectrum anti-viral ivermectin targets the host nuclear transport importin α/βI heterodimer, Antivir Res
Yang, Qi, Farias-Pereira, Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocyte, Food Chem Toxicol
Yates, Wolstenholme, An ivermectin sensitive glutamate-gated chloride channel subunit from Dirafilaria immitis, Int J Parasitol
Zhang, Ni, Zhang, Ivermectin confers its cytostatic effect by inducing AMPK/ mTOR-mediated autophagy and DNA damage, Chemosph
Ōmura, Crump, The life and times of ivermectin: A success story, Nat Rev Microbiol
DOI record:
{
"DOI": "10.4314/ajcem.v22i3.2",
"ISSN": [
"1595-689X"
],
"URL": "http://dx.doi.org/10.4314/ajcem.v22i3.2",
"abstract": "<jats:p>Ivermectin is an avermectin which is a group of pentacyclic sixteen-membered lactone (macrocyclic lactone disaccharide) derived from the soil bacterium Streptomyces avermitilis. It is a semi-synthetic broad-spectrum anti-helminthic, anti-viral and anti-cancer agent. It has a wide safety margin with low adverse effects when it is used orally. It has, however, so far only been approved by the Food and Drug Administration (FDA) as a broad spectrum anti-parasitic agent. Because ivermectin also has broad activities as an anti-viral agent, we herein review its pharmacokinetic and pharmacodynamic activities, as well as the in vitro and in vivo studies conducted on the drug. It is hoped that this work will pave way for ivermectin being seriously considered as an addition to the drugs available for the management of patients with COVID-19.
\nKeywords: ivermectin; pharmacokinetics; pharmacodynamics; broad-spectrum anti-viral; COVID-19</jats:p>",
"author": [
{
"affiliation": [],
"family": "Adegboro",
"given": "B.",
"sequence": "first"
},
{
"affiliation": [],
"family": "Lawani",
"given": "O.A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Oriaifo",
"given": "S.E.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Abayomi",
"given": "S.A.",
"sequence": "additional"
}
],
"container-title": "African Journal of Clinical and Experimental Microbiology",
"container-title-short": "Af J Clin Exp Micro",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2021,
7,
5
]
],
"date-time": "2021-07-05T14:41:18Z",
"timestamp": 1625496078000
},
"deposited": {
"date-parts": [
[
2021,
7,
5
]
],
"date-time": "2021-07-05T14:41:32Z",
"timestamp": 1625496092000
},
"indexed": {
"date-parts": [
[
2024,
4,
1
]
],
"date-time": "2024-04-01T15:51:26Z",
"timestamp": 1711986686424
},
"is-referenced-by-count": 1,
"issue": "3",
"issued": {
"date-parts": [
[
2021,
7,
2
]
]
},
"journal-issue": {
"issue": "3",
"published-online": {
"date-parts": [
[
2021,
7,
2
]
]
}
},
"link": [
{
"URL": "https://www.ajol.info/index.php/ajcem/article/download/209853/197857",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.ajol.info/index.php/ajcem/article/download/209853/197857",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "2895",
"original-title": [],
"page": "322-329",
"prefix": "10.4314",
"published": {
"date-parts": [
[
2021,
7,
2
]
]
},
"published-online": {
"date-parts": [
[
2021,
7,
2
]
]
},
"publisher": "African Journals Online (AJOL)",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.ajol.info/index.php/ajcem/article/view/209853"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "A review of the anti-viral effects of ivermectin",
"type": "journal-article",
"volume": "22"
}
